Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Invasive Candidiasis in Infants and Children: Recent Advances in Epidemiology, Diagnosis, and Treatment.

Walsh TJ, Katragkou A, Chen T, Salvatore CM, Roilides E.

J Fungi (Basel). 2019 Jan 24;5(1). pii: E11. doi: 10.3390/jof5010011. Review.

2.

Recent Advances in the Treatment of Scedosporiosis and Fusariosis.

McCarthy MW, Katragkou A, Iosifidis E, Roilides E, Walsh TJ.

J Fungi (Basel). 2018 Jun 18;4(2). pii: E73. doi: 10.3390/jof4020073. Review.

3.

Diagnostic Imaging and Invasive Fungal Diseases in Children.

Katragkou A, Fisher BT, Groll AH, Roilides E, Walsh TJ.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(suppl_1):S22-S31. doi: 10.1093/jpids/pix055. Review.

PMID:
28927203
4.

In vitro combination therapy with isavuconazole against Candida spp.

Katragkou A, McCarthy M, Meletiadis J, Hussain K, Moradi PW, Strauss GE, Myint KL, Zaw MH, Kovanda LL, Petraitiene R, Roilides E, Walsh TJ, Petraitis V.

Med Mycol. 2017 Nov 1;55(8):859-868. doi: 10.1093/mmy/myx006.

PMID:
28204571
5.

Micafungin alters the amino acid, nucleic acid and central carbon metabolism of Candida albicans at subinhibitory concentrations: novel insights into mechanisms of action.

Katragkou A, Williams M, Sternberg S, Pantazatos D, Roilides E, Walsh TJ.

J Antimicrob Chemother. 2017 Mar 1;72(3):712-716. doi: 10.1093/jac/dkw478.

6.

Comparison of cotrimoxazole vs. second-generation cephalosporins for prevention of urinary tract infections in children.

Antachopoulos C, Ioannidou M, Tratselas A, Iosifidis E, Katragkou A, Kadiltzoglou P, Kollios K, Roilides E.

Pediatr Nephrol. 2016 Dec;31(12):2271-2276. Epub 2016 Aug 15.

PMID:
27525699
7.

Can repurposing of existing drugs provide more effective therapies for invasive fungal infections?

Katragkou A, Roilides E, Walsh TJ.

Expert Opin Pharmacother. 2016 Jun;17(9):1179-82. doi: 10.1080/14656566.2016.1186647. No abstract available.

PMID:
27217005
8.

Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis.

Petraitis V, Petraitiene R, Moradi PW, Strauss GE, Katragkou A, Kovanda LL, Hope WW, Walsh TJ.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2718-26. doi: 10.1128/AAC.02665-15. Print 2016 May.

9.

Effects of fluconazole on the metabolomic profile of Candida albicans.

Katragkou A, Alexander EL, Eoh H, Raheem SK, Roilides E, Walsh TJ.

J Antimicrob Chemother. 2016 Mar;71(3):635-40. doi: 10.1093/jac/dkv381. Epub 2015 Dec 13.

PMID:
26668236
10.

Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces.

Katragkou A, Roilides E, Walsh TJ.

Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S622-9. doi: 10.1093/cid/civ746. Review.

PMID:
26567280
11.

The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.

Ghannoum M, Roilides E, Katragkou A, Petraitis V, Walsh TJ.

Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S618-21. doi: 10.1093/cid/civ815.

PMID:
26567279
12.

How Biofilms Evade Host Defenses.

Roilides E, Simitsopoulou M, Katragkou A, Walsh TJ.

Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MB-0012-2014. Review.

PMID:
26185085
13.

In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.

Katragkou A, McCarthy M, Alexander EL, Antachopoulos C, Meletiadis J, Jabra-Rizk MA, Petraitis V, Roilides E, Walsh TJ.

J Antimicrob Chemother. 2015 Feb;70(2):470-8. doi: 10.1093/jac/dku374. Epub 2014 Oct 6.

14.

BCG vaccination policy in Greece: time for another review?

Gabriele F, Katragkou A, Roilides E.

Int J Tuberc Lung Dis. 2014 Oct;18(10):1258. doi: 10.5588/ijtld.14.0282. No abstract available.

PMID:
25216844
15.

In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds.

Katragkou A, McCarthy M, Meletiadis J, Petraitis V, Moradi PW, Strauss GE, Fouant MM, Kovanda LL, Petraitiene R, Roilides E, Walsh TJ.

Antimicrob Agents Chemother. 2014 Nov;58(11):6934-7. doi: 10.1128/AAC.03261-14. Epub 2014 Aug 18.

16.

Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit.

Tsiatsiou O, Iosifidis Ε, Katragkou A, Dimou V, Sarafidis K, Karampatakis T, Antachopoulos C, Orfanou A, Tsakris A, Drossou-Agakidou V, Roilides E.

Eur J Pediatr. 2015 Jan;174(1):65-74. doi: 10.1007/s00431-014-2365-8. Epub 2014 Jul 2.

PMID:
24985124
17.

Exserohilum infections: review of 48 cases before the 2012 United States outbreak.

Katragkou A, Pana ZD, Perlin DS, Kontoyiannis DP, Walsh TJ, Roilides E.

Med Mycol. 2014 May;52(4):376-86. doi: 10.1093/mmy/myt030. Epub 2014 Mar 28.

PMID:
24682112
18.

Current management of late onset neonatal bacterial sepsis in five European countries.

Lutsar I, Chazallon C, Carducci FI, Trafojer U, Abdelkader B, de Cabre VM, Esposito S, Giaquinto C, Heath PT, Ilmoja ML, Katragkou A, Lascoux C, Metsvaht T, Mitsiakos G, Netzer E, Pugni L, Roilides E, Saidi Y, Sarafidis K, Sharland M, Usonis V, Aboulker JP; NeoMero Consortium.

Eur J Pediatr. 2014 Aug;173(8):997-1004. doi: 10.1007/s00431-014-2279-5. Epub 2014 Feb 13.

PMID:
24522326
19.

Why is mucormycosis more difficult to cure than more common mycoses?

Katragkou A, Walsh TJ, Roilides E.

Clin Microbiol Infect. 2014 Jun;20 Suppl 6:74-81. doi: 10.1111/1469-0691.12466. Epub 2014 Jan 28. Review.

20.

Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.

Simitsopoulou M, Peshkova P, Tasina E, Katragkou A, Kyrpitzi D, Velegraki A, Walsh TJ, Roilides E.

Antimicrob Agents Chemother. 2013 Jun;57(6):2562-70. doi: 10.1128/AAC.02541-12. Epub 2013 Mar 25.

21.

Drug-resistant tuberculosis in two children in Greece: report of the first extensively drug-resistant case.

Katragkou A, Antachopoulos C, Hatziagorou E, Sdougka M, Roilides E, Tsanakas J.

Eur J Pediatr. 2013 Apr;172(4):563-7. doi: 10.1007/s00431-012-1811-8. Epub 2012 Aug 21.

PMID:
22907397
22.

Attitudes regarding occupational vaccines and vaccination coverage against vaccine-preventable diseases among healthcare workers working in pediatric departments in Greece.

Maltezou HC, Lourida A, Katragkou A, Grivea IN, Katerelos P, Wicker S, Syrogiannopoulos GA, Roilides E, Theodoridou M.

Pediatr Infect Dis J. 2012 Jun;31(6):623-5. doi: 10.1097/INF.0b013e31824ddc1e.

PMID:
22333705
23.

Serum levels of daptomycin in pediatric patients.

Antachopoulos C, Iosifidis E, Sarafidis K, Bazoti F, Gikas E, Katragkou A, Drossou-Agakidou V, Roilides E.

Infection. 2012 Aug;40(4):367-71. doi: 10.1007/s15010-011-0240-3. Epub 2012 Jan 21.

PMID:
22271402
24.

Modulating the immune system against fungal infections--where are we?

Roilides E, Katragkou A.

Clin Microbiol Infect. 2012 Feb;18(2):110-1. doi: 10.1111/j.1469-0691.2011.03747.x. No abstract available.

25.

Immunotherapy against invasive mold infections.

Antachopoulos C, Katragkou A, Roilides E.

Immunotherapy. 2012 Jan;4(1):107-20. doi: 10.2217/imt.11.159. Review.

PMID:
22150004
26.

Immunotherapy of infections caused by rare filamentous fungi.

Katragkou A, Roilides E.

Clin Microbiol Infect. 2012 Feb;18(2):134-9. doi: 10.1111/j.1469-0691.2011.03689.x. Epub 2011 Nov 1. Review.

27.

Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece.

Maltezou HC, Katerelos P, Mavrouli M, Lourida A, Routsias JG, Spanakis N, Maragos A, Tedoma A, Bassiakos Y, Koratzanis G, Mantagos S, Metallidis S, Katragkou A, Nikolaidis P, Roilides E, Theodoridou M, Tsakris A.

Vaccine. 2011 Sep 2;29(38):6664-9. doi: 10.1016/j.vaccine.2011.06.098. Epub 2011 Jul 14.

PMID:
21762749
28.

Posaconazole: when and how? The clinician's view.

Katragkou A, Tsikopoulou F, Roilides E, Zaoutis TE.

Mycoses. 2012 Mar;55(2):110-22. doi: 10.1111/j.1439-0507.2011.02061.x. Epub 2011 Jul 18. Review.

PMID:
21762211
29.

Effects of interferon-γ and granulocyte colony-stimulating factor on antifungal activity of human polymorphonuclear neutrophils against Candida albicans grown as biofilms or planktonic cells.

Katragkou A, Simitsopoulou M, Chatzimoschou A, Georgiadou E, Walsh TJ, Roilides E.

Cytokine. 2011 Sep;55(3):330-4. doi: 10.1016/j.cyto.2011.05.007.

PMID:
21641233
30.

Best practice in treating infants and children with proven, probable or suspected invasive fungal infections.

Katragkou A, Roilides E.

Curr Opin Infect Dis. 2011 Jun;24(3):225-9. doi: 10.1097/QCO.0b013e3283460e22. Review.

PMID:
21455060
31.

Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.

Chatzimoschou A, Katragkou A, Simitsopoulou M, Antachopoulos C, Georgiadou E, Walsh TJ, Roilides E.

Antimicrob Agents Chemother. 2011 May;55(5):1968-74. doi: 10.1128/AAC.00959-10. Epub 2011 Feb 22.

32.

Additive antifungal activity of anidulafungin and human neutrophils against Candida parapsilosis biofilms.

Katragkou A, Chatzimoschou A, Simitsopoulou M, Georgiadou E, Roilides E.

J Antimicrob Chemother. 2011 Mar;66(3):588-91. doi: 10.1093/jac/dkq466. Epub 2010 Dec 7.

PMID:
21138910
33.

Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents.

Katragkou A, Kruhlak MJ, Simitsopoulou M, Chatzimoschou A, Taparkou A, Cotten CJ, Paliogianni F, Diza-Mataftsi E, Tsantali C, Walsh TJ, Roilides E.

J Infect Dis. 2010 Jun 15;201(12):1941-9. doi: 10.1086/652783.

34.

A prospective multicenter study of childhood encephalitis in Greece.

Galanakis E, Tzoufi M, Katragkou A, Nakou I, Roilides E.

Pediatr Infect Dis J. 2009 Aug;28(8):740-2. doi: 10.1097/INF.0b013e318199eff9.

PMID:
19633519
35.

Serotype distribution and antibiotic resistance of human gastrointestinal isolates of Salmonella enterica from Crete, Greece.

Maraki S, Mantadakis E, Nioti E, Katragkou A, Samonis G.

J Chemother. 2009 Apr;21(2):222-5. No abstract available.

PMID:
19423479
36.

Zygomycosis in neonates: an uncommon but life-threatening infection.

Roilides E, Zaoutis TE, Katragkou A, Benjamin DK Jr, Walsh TJ.

Am J Perinatol. 2009 Sep;26(8):565-73. doi: 10.1055/s-0029-1220775. Epub 2009 Apr 23. Review.

PMID:
19391079
37.

Host immune response against Scedosporium species.

Roilides E, Simitsopoulou M, Katragkou A, Walsh TJ.

Med Mycol. 2009 Jun;47(4):433-40. doi: 10.1080/13693780902738006. Epub 2009 Jan 31. Review.

PMID:
19184770
38.

Spinal cord compression in an adolescent with relapsed B-precursor acute lymphoblastic leukemia and mental neuropathy.

Mantadakis E, Katragkou A, Papadaki E, Papadhimitriou S, Paterakis G, Stiakaki E, Kalmanti M.

Int J Hematol. 2008 Oct;88(3):294-298. doi: 10.1007/s12185-008-0159-3. Epub 2008 Sep 18.

PMID:
18797986
39.

Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece.

Iosifidis E, Antachopoulos C, Tsivitanidou M, Katragkou A, Farmaki E, Tsiakou M, Kyriazi T, Sofianou D, Roilides E.

Infect Control Hosp Epidemiol. 2008 Jul;29(7):615-22. doi: 10.1086/589333.

PMID:
18624668
40.

Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms.

Katragkou A, Chatzimoschou A, Simitsopoulou M, Dalakiouridou M, Diza-Mataftsi E, Tsantali C, Roilides E.

Antimicrob Agents Chemother. 2008 Jan;52(1):357-60. Epub 2007 Oct 15.

41.

Scedosporium apiospermum infection after near-drowning.

Katragkou A, Dotis J, Kotsiou M, Tamiolaki M, Roilides E.

Mycoses. 2007 Sep;50(5):412-21. Review.

PMID:
17714363
42.

Immunomodulatory therapy in yeast infections.

Garbino J, Katragkou A, Roilides E.

Expert Rev Anti Infect Ther. 2007 Feb;5(1):129-40. Review.

PMID:
17266460
43.

Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study.

Katragkou A, Kotsiou M, Antachopoulos C, Benos A, Sofianou D, Tamiolaki M, Roilides E.

Intensive Care Med. 2006 Sep;32(9):1384-91. Epub 2006 Jun 21.

PMID:
16788807
44.

Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin.

Katragkou A, Roilides E.

J Clin Microbiol. 2005 Sep;43(9):4916-7. No abstract available.

Supplemental Content

Loading ...
Support Center